Emily Carbone
Impact in
-
- Cancer Genomics and Diagnostics
- Cancer, Lipids, and Metabolism
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 11
-
- Cancer Genomics and Diagnostics 4
- Co-authors
- Howard I. Scher (14 shared papers)Ethan Barnett (11 shared papers)Melanie Hullings (4 shared papers)Ryan Dittamore (3 shared papers)Ryon P. Graf (3 shared papers)Nikolaus Schultz (3 shared papers)David B. Solit (3 shared papers)Wassim Abida (4 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)European Urology (2 papers)Journal of Visualized Experiments (2 papers)The Prostate (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
Emily Carbone
16 papers receiving 340 citations
Peers
Comparison fields: 5 of 46
- Cancer Research 116
- Pulmonary and Respiratory Medicine 201
- Oncology 103
- Molecular Biology 86
- Radiology, Nuclear Medicine and Imaging 21
Countries citing papers authored by Emily Carbone
This map shows the geographic impact of Emily Carbone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Carbone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Carbone more than expected).
Fields of papers citing papers by Emily Carbone
This network shows the impact of papers produced by Emily Carbone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Carbone. The network helps show where Emily Carbone may publish in the future.
Co-authors
The 25 scholars most cited alongside Emily Carbone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 126 | |
| 2 | 2019 | 60 | |
| 3 | 2021 | 33 | |
| 4 | 2020 | 33 | |
| 5 | 2017 | 31 | |
| 6 | Considerations about tumor size as a factor of prognosis in NSCLC. | 2000 | 14 |
| 7 | 2018 | 10 | |
| 8 | 2022 | 10 | |
| 9 | 2020 | 9 | |
| 10 | 2022 | 4 | |
| 11 | 2017 | 4 | |
| 12 | 2021 | 3 | |
| 13 | 2018 | 3 | |
| 14 | 2023 | 1 | |
| 15 | 2017 | 1 | |
| 16 | 2022 | 1 | |
| 17 | 2023 | 0 | |
| 18 | 2020 | 0 |
About Emily Carbone
Emily Carbone is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Molecular Biology and Cellular and Molecular Neuroscience, having authored 18 papers that have together received 343 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (11 papers), Cancer Genomics and Diagnostics (4 papers), Mitochondrial Function and Pathology (3 papers), Genetic Neurodegenerative Diseases (3 papers), Metabolism and Genetic Disorders (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Radiomics and Machine Learning in Medical Imaging (1 paper) and Amyotrophic Lateral Sclerosis Research (1 paper). The work is most often cited by research in Cancer Research (116 citations), Pulmonary and Respiratory Medicine (201 citations), Oncology (103 citations), Molecular Biology (86 citations) and Radiology, Nuclear Medicine and Imaging (21 citations). Emily Carbone has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Howard I. Scher, Ethan Barnett, Melanie Hullings, Ryan Dittamore, Ryon P. Graf, Nikolaus Schultz, David B. Solit, Wassim Abida, Michael J. Morris and Philip W. Kantoff. Their work appears in journals such as Journal of Clinical Oncology, European Urology, Journal of Visualized Experiments, The Prostate and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.